BYSL Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-36532
Conjugate
Catalog #
Key Product Details
Validated by
Biological Validation
Species Reactivity
Human
Applications
Immunoprecipitation (Negative), Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
1.0 mg/ml
Product Specifications
Immunogen
The immunogen recognized by the antibody maps to a region between residue 1 to 50 of human Bystin using the numbering given in entry NP_004044.3.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for BYSL Antibody
Western Blot: BYSL Antibody [NBP2-36532]
Western Blot: BYSL Antibody [NBP2-36532] - Samples: Whole cell lysate (50 ug) from HeLa, 293T, and Jurkat cells prepared using NETN lysis buffer. Antibodies: Affinity purified rabbit anti-Bystin antibody used for WB at 0.4 ug/ml. Detection: Chemiluminescence with an exposure time of 3 minutes.Applications for BYSL Antibody
Application
Recommended Usage
Western Blot
1:1000 - 1:5000
Application Notes
Antibody concentration was determined by extinction coefficient: absorbance at 280 nm of 1.4 equals 1.0 mg of IgG.
Validation by IP/Western Blot was performed using a 4-20% SDS-PAGE gel.
Validation by IP/Western Blot was performed using a 4-20% SDS-PAGE gel.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris-Citrate/Phosphate (pH 7.0 - 8.0)
Preservative
0.09% Sodium Azide
Concentration
1.0 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: BYSL
Alternate Names
by the ribosomal protein s6 gene, drosophila, homolog-like, BYSTIN, bystin-like
Gene Symbol
BYSL
UniProt
Additional BYSL Products
Product Documents for BYSL Antibody
Product Specific Notices for BYSL Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...